Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10776
PUT
Neumora Therapeutics
NMRA
$261M
| $136K | ﹤0.01% |
10,300
-35,400
| -77% | -$413K |
|
10777
CALL
Acumen Pharmaceuticals
ABOS
$211M
| $136K | ﹤0.01% |
54,800
-104,800
| -66% | -$284K |
|
|
STKL
10778
PUT
DELISTED
SunOpta
STKL
| $136K | ﹤0.01% |
21,300
+1,500
| +8% | +$8.79K |
|
10779
CALL
MacroGenics
MGNX
$263M
| $136K | ﹤0.01% |
41,300
+1,500
| +4% | +$5.84K |
|
|
NFGC
10780
PUT
New Found Gold
NFGC
$734M
| $136K | ﹤0.01% |
53,600
+2,600
| +5% | +$7.13K |
|
10781
CALL
Offerpad Solutions
OPAD
$21.3M
| $136K | ﹤0.01% |
+3,340
| New | +$134K |
|
10782
Relmada Therapeutics
RLMD
$462M
| $135K | ﹤0.01% |
41,730
-26,406
| -39% | -$85.5K |
|
10783
Nuveen Real Estate Income Fund
JRS
$243M
| $135K | ﹤0.01% |
+14,528
| New | +$124K |
|
10784
Ooma
OOMA
$629M
| $135K | ﹤0.01% |
11,843
+228
| +2% | +$2.25K |
|
|
10785
PUT
MacroGenics
MGNX
$263M
| $135K | ﹤0.01% |
41,000
-12,300
| -23% | -$47.9K |
|
10786
Trevi Therapeutics
TRVI
$2.39B
| $135K | ﹤0.01% |
+40,378
| New | +$120K |
|
|
DHC
10787
Diversified Healthcare Trust
DHC
$1.85B
| $135K | ﹤0.01% |
32,174
+20,502
| +176% | +$69.1K |
|
10788
Absci
ABSI
$1.49B
| $135K | ﹤0.01% |
35,276
-69,333
| -66% | -$276K |
|
10789
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$892M
| $135K | ﹤0.01% |
+12,019
| New | +$133K |
|
10790
PUT
CPI Aerostructures
CVU
$71.7M
| $135K | ﹤0.01% |
39,100
+10,300
| +36% | +$27.7K |
|
|
WOW
10791
PUT
DELISTED
WideOpenWest
WOW
| $134K | ﹤0.01% |
25,600
-6,300
| -20% | -$33.6K |
|
|
AP.WS
10792
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
| $134K | ﹤0.01% |
1,276,666
| – | – |
|
|
10793
Acumen Pharmaceuticals
ABOS
$211M
| $134K | ﹤0.01% |
54,019
-61
| -0.1% | -$165 |
|
10794
Hennessy Advisors
HNNA
$80.1M
| $134K | ﹤0.01% |
13,449
-21,382
| -61% | -$193K |
|
|
BFK
10795
DELISTED
BlackRock Municipal Income Trust
BFK
| $134K | ﹤0.01% |
+12,650
| New | +$131K |
|
10796
PUT
Smartbird Inc
BIRD
$30M
| $133K | ﹤0.01% |
11,300
+10,535
| +1,377% | +$133K |
|
10797
Barnes & Noble Education
BNED
$415M
| $133K | ﹤0.01% |
+14,354
| New | +$148K |
|
|
TBHC
10798
DELISTED
The Brand House Collective
TBHC
| $133K | ﹤0.01% |
60,622
+18,350
| +43% | +$30.8K |
|
|
HEQ
10799
John Hancock Hedged Equity & Income Fund
HEQ
$140M
| $133K | ﹤0.01% |
12,102
-5,290
| -30% | -$56.1K |
|
10800
GCM Grosvenor
GCMG
$839M
| $132K | ﹤0.01% |
+11,697
| New | +$126K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.